Research Topics
| M J ZelefskySummaryAffiliation: Memorial Sloan-Kettering Cancer Center Country: USA Publications
| Collaborators
|
Detail Information
Publications
Analysis of biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer using dose-distribution variables and tumor control probability modelsS Levegrun
Department Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 47:1245-60. 2000..To investigate tumor control following three-dimensional conformal radiation therapy (3D-CRT) of prostate cancer and to identify dose-distribution variables that correlate with local control assessed through posttreatment prostate biopsies...
Late rectal bleeding after conformal radiotherapy of prostate cancer. II. Volume effects and dose-volume histogramsA Jackson
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 49:685-98. 2001..The purpose of this study is to identify features of the cumulative dose-volume histogram (DVH) for the rectal wall that correlate with late rectal bleeding after 3D-CRT for prostate cancer...
Secondary cancers after intensity-modulated radiotherapy, brachytherapy and radical prostatectomy for the treatment of prostate cancer: incidence and cause-specific survival outcomes according to the initial treatment interventionMichael J Zelefsky
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
BJU Int 110:1696-701. 2012..In this report we also note that even among patients who develop second cancers, if detected earlier, the majority are alive 5 years after the diagnosis...
Dose escalation for prostate cancer radiotherapy: predictors of long-term biochemical tumor control and distant metastases-free survival outcomesMichael J Zelefsky
Departments of Radiation Oncology, Medical Physics, and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Eur Urol 60:1133-9. 2011..Higher radiation dose levels have been shown to be associated with improved tumor-control outcomes in localized prostate cancer (PCa) patients...
How to select the optimal therapy for early-stage prostate cancerMarisa A Kollmeier
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10065, USA
Crit Rev Oncol Hematol 84:e6-e15. 2012..This review will discuss the relevant issues in the decision making and treatment selection for the patient...
Results from the Quality Research in Radiation Oncology (QRRO) survey: Evaluation of dosimetric outcomes for low-dose-rate prostate brachytherapyMichael J Zelefsky
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Brachytherapy 12:19-24. 2013..We report on quality of dose delivery to target and normal tissues from low-dose-rate prostate brachytherapy using postimplantation dosimetric evaluations from a random sample of U.S. patients...
Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancerMichael J Zelefsky
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Int J Radiat Oncol Biol Phys 84:125-9. 2012..To compare toxicity profiles and biochemical tumor control outcomes between patients treated with high-dose image-guided radiotherapy (IGRT) and high-dose intensity-modulated radiotherapy (IMRT) for clinically localized prostate cancer...
Predicting biochemical tumor control after brachytherapy for clinically localized prostate cancer: The Memorial Sloan-Kettering Cancer Center experienceMichael J Zelefsky
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Brachytherapy 11:245-9. 2012..To identify predictors of biochemical tumor control and present an updated prognostic nomogram for patients with clinically localized prostate cancer treated with brachytherapy...
Incidence of secondary cancer development after high-dose intensity-modulated radiotherapy and image-guided brachytherapy for the treatment of localized prostate cancerMichael J Zelefsky
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Int J Radiat Oncol Biol Phys 83:953-9. 2012..To report the incidence and excess risk of second malignancy (SM) development compared with the general population after external beam radiotherapy (EBRT) and brachytherapy to treat prostate cancer...
Tumor control outcomes after hypofractionated and single-dose stereotactic image-guided intensity-modulated radiotherapy for extracranial metastases from renal cell carcinomaMichael J Zelefsky
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Int J Radiat Oncol Biol Phys 82:1744-8. 2012..To report tumor local progression-free outcomes after treatment with single-dose, image-guided, intensity-modulated radiotherapy and hypofractionated regimens for extracranial metastases from renal cell primary tumors...
Pretreatment nomogram predicting ten-year biochemical outcome of three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for prostate cancerMichael J Zelefsky
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Urology 70:283-7. 2007....
Postradiotherapy 2-year prostate-specific antigen nadir as a predictor of long-term prostate cancer mortalityMichael J Zelefsky
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Int J Radiat Oncol Biol Phys 75:1350-6. 2009..To report the influence of posttreatment prostate-specific antigen (PSA) nadir response at 2 years after external beam radiotherapy (RT) on distant metastases (DM) and cause-specific mortality (CSM)...
Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancerMichael J Zelefsky
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Int J Radiat Oncol Biol Phys 70:1124-9. 2008..To report the incidence and predictors of treatment-related toxicity at 10 years after three-dimensional conformal radiotherapy (3D-CRT) and intensity-modulated radiotherapy (IMRT) for localized prostate cancer...
Three-dimensional conformal brachytherapy for prostate cancerMichael J Zelefsky
Brachytherapy Service, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Curr Urol Rep 5:173-8. 2004..Such approaches will minimize the possibility of tumor underdosage and further enhance the conformality of prostate brachytherapy...
Comparison of tumor control and toxicity outcomes of high-dose intensity-modulated radiotherapy and brachytherapy for patients with favorable risk prostate cancerMichael J Zelefsky
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Urology 77:986-90. 2011..To compare the long-term, prostate-specific antigen relapse-free survival outcome and incidence of toxicity for patients with low-risk prostate cancer who underwent brachytherapy or intensity-modulated radiotherapy (RT)...
Improved conformality and decreased toxicity with intraoperative computer-optimized transperineal ultrasound-guided prostate brachytherapyMichael J Zelefsky
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 55:956-63. 2003..We report the preliminary outcome of patients with localized prostate cancer treated with this approach...
Real-time intraoperative computed tomography assessment of quality of permanent interstitial seed implantation for prostate cancerMichael J Zelefsky
Department of Radiation Oncology, Brachytherapy Service, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
Urology 76:1138-42. 2010..To evaluate the use of real-time kilovoltage cone-beam computed tomography (CBCT) during prostate brachytherapy for intraoperative dosimetric assessment and correcting deficient dose regions...
Combined brachytherapy with external beam radiotherapy for localized prostate cancer: reduced morbidity with an intraoperative brachytherapy planning technique and supplemental intensity-modulated radiation therapyMichael J Zelefsky
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Brachytherapy 7:1-6. 2008....
Intensity-modulated radiation therapy for prostate cancerMichael J Zelefsky
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Semin Radiat Oncol 12:229-37. 2002..Clinical trials will be necessary to define more clearly the true extent of improved tumor control and reduction in normal tissue complications with IMRT in the treatment of prostate cancer...
Changing trends in national practice for external beam radiotherapy for clinically localized prostate cancer: 1999 Patterns of Care survey for prostate cancerMichael J Zelefsky
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 59:1053-61. 2004..To report changing trends in external beam radiotherapy (EBRT) delivery practice for clinically localized prostate cancer as determined from the 1999 survey from the American College of Radiology National Patterns of Care Study...
High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patientsMichael J Zelefsky
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 53:1111-6. 2002..To report the acute and late toxicity and preliminary biochemical outcomes in 772 patients with clinically localized prostate cancer treated with high-dose intensity-modulated radiotherapy (IMRT)...
Metastasis after radical prostatectomy or external beam radiotherapy for patients with clinically localized prostate cancer: a comparison of clinical cohorts adjusted for case mixMichael J Zelefsky
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
J Clin Oncol 28:1508-13. 2010..We assessed the effect of radical prostatectomy (RP) and external beam radiotherapy (EBRT) on distant metastases (DM) rates in patients with localized prostate cancer treated with RP or EBRT at a single specialized cancer center...
Outcome predictors for the increasing PSA state after definitive external-beam radiotherapy for prostate cancerMichael J Zelefsky
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
J Clin Oncol 23:826-31. 2005..To identify predictors of distant metastases (DM) among patients who develop an isolated prostate-specific antigen (PSA) relapse after definitive external-beam radiotherapy for clinically localized prostate cancer...
Influence of local tumor control on distant metastases and cancer related mortality after external beam radiotherapy for prostate cancerMichael J Zelefsky
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
J Urol 179:1368-73; discussion 1373. 2008..In addition, we report the influence of local tumor control on long-term distant metastases and cause specific survival outcomes...
Five-year biochemical outcome and toxicity with transperineal CT-planned permanent I-125 prostate implantation for patients with localized prostate cancerM J Zelefsky
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 47:1261-6. 2000....
PSA bounce versus biochemical failure following prostate brachytherapyMichael J Zelefsky
Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10024, USA
Nat Clin Pract Urol 3:578-9. 2006
Predictors of improved outcome for patients with localized prostate cancer treated with neoadjuvant androgen ablation therapy and three-dimensional conformal radiotherapyM J Zelefsky
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021 6007, USA
J Clin Oncol 16:3380-5. 1998....
Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantationMichael J Zelefsky
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 67:327-33. 2007..To assess long-term prostate-specific antigen (PSA) outcome after permanent prostate brachytherapy (BT) and identify predictors of improved disease-free survival...
Evaluation of postradiotherapy PSA patterns and correlation with 10-year disease free survival outcomes for prostate cancerMichael J Zelefsky
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 66:382-8. 2006....
Postimplantation dosimetric analysis of permanent transperineal prostate implantation: improved dose distributions with an intraoperative computer-optimized conformal planning techniqueM J Zelefsky
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 48:601-8. 2000..To compare the target coverage and dose to normal tissues after I-125 transperineal permanent implantation (TPI) of the prostate in 90 patients treated with one of three different transperineal techniques...
Long-term outcome following three-dimensional conformal/intensity-modulated external-beam radiotherapy for clinical stage T3 prostate cancerMichael J Zelefsky
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Eur Urol 53:1172-9. 2008..To report the long-term tumor control and survival outcomes after conformal external-beam radiotherapy for patients with clinical stage T3 prostate cancer...
Long-term outcome of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancerMichael J Zelefsky
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
J Urol 176:1415-9. 2006..We report on the long-term results and late toxicity outcomes of high dose intensity modulated radiation therapy for patients with clinically localized prostate cancer...
Intraoperative real-time planned conformal prostate brachytherapy: post-implantation dosimetric outcome and clinical implicationsMichael J Zelefsky
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY10021, USA
Radiother Oncol 84:185-9. 2007..To report the dosimetric outcome of patients with clinically localized prostate cancer treated with I-125 permanent implantation using an intraoperative real-time conformal planning technique...
Long-term results of conformal radiotherapy for prostate cancer: impact of dose escalation on biochemical tumor control and distant metastases-free survival outcomesMichael J Zelefsky
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Int J Radiat Oncol Biol Phys 71:1028-33. 2008..To report prostate-specific antigen (PSA) relapse-free survival and distant metastases-free survival (DMFS) outcomes for patients with clinically localized prostate cancer treated with high-dose conformal radiotherapy...
Five-year outcome of intraoperative conformal permanent I-125 interstitial implantation for patients with clinically localized prostate cancerMichael J Zelefsky
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 67:65-70. 2007..To report the 5-year tumor control and toxicity outcomes for patients with localized prostate treated with I-125 permanent implantation using an intraoperative real-time conformal planning technique...
Results of a phase II study using estramustine phosphate and vinblastine in combination with high-dose three-dimensional conformal radiotherapy for patients with locally advanced prostate cancerM J Zelefsky
Department of Radiation Oncology, Solid Tumor Service, Department of Medical Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
J Clin Oncol 18:1936-41. 2000..To assess the feasibility and tolerance of neoadjuvant and concomitant estramustine phosphate and vinblastine (EV) with high-dose three-dimensional conformal radiotherapy (3D-CRT) for patients with unfavorable-risk prostate cancer...
Late rectal toxicity after conformal radiotherapy of prostate cancer (I): multivariate analysis and dose-responseM W Skwarchuk
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, NY, USA
Int J Radiat Oncol Biol Phys 47:103-13. 2000....
Treatment planning for prostate implants using magnetic-resonance spectroscopy imagingM Zaider
Departments of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 47:1085-96. 2000..A method is described that registers MRSI to intraoperative-obtained ultrasound images and incorporates this information into a treatment-planning system to achieve dose escalation to intraprostatic tumor deposits...
Accelerated concomitant boost radiotherapy and chemotherapy for advanced nasopharyngeal carcinomaS L Wolden
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 19:1105-10. 2001..To evaluate the feasibility and efficacy of concomitant boost radiotherapy (RT) plus cisplatin-based chemotherapy compared with standard fractionation RT for patients with advanced nasopharyngeal cancer...
Fitting tumor control probability models to biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer: pitfalls in deducing radiobiologic parameters for tumors from clinical dataS Levegrun
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Int J Radiat Oncol Biol Phys 51:1064-80. 2001..We discuss differences in the radiobiologic parameters and dose-response curves and demonstrate pitfalls in interpreting the results...
Five-year outcomes after neoadjuvant chemotherapy and conformal radiotherapy in patients with high-risk localized prostate cancerCharles J Ryan
Genitourinary Oncology Service, Department of Medicine, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Urology 64:90-4. 2004..These long-term findings support the continued study of chemotherapy combined with RT as a potential alternative to prolonged androgen deprivation...
Technological advances in external-beam radiation therapy for the treatment of localized prostate cancerSteven A Leibel
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Semin Oncol 30:596-615. 2003..In some patients, both approaches may be necessary to maximize the probability of cure. In view of the favorable benefit-risk ratio of high-dose IMRT, the design of clinical trials to resolve these critical questions is essential...
Improved long-term survival with combined modality therapy for pediatric nasopharynx cancerS L Wolden
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 46:859-64. 2000..33%, p < 0.05) over radiation alone. The 10-year actuarial rate of severe complications was 24%.60 Gy are used for gross disease. The addition of chemotherapy decreases the risk of distant metastases and increases survival...
High dose radiation delivered by intensity modulated conformal radiotherapy improves the outcome of localized prostate cancerM J Zelefsky
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
J Urol 166:876-81. 2001..Intensity modulated radiation therapy is associated with minimal rectal and bladder toxicity, and, hence, represents the treatment delivery approach with the most favorable risk-to-benefit ratio...
High-dose-rate interstitial brachytherapy in recurrent and previously irradiated head and neck cancers--preliminary resultsAshwatha Narayana
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Brachytherapy 6:157-63. 2007..We report our preliminary results in patients with recurrent H&N cancers treated with interstitial HDRBT...
Predictors of biochemical outcome with salvage conformal radiotherapy after radical prostatectomy for prostate cancerMatthew S Katz
Departments of Radiation Oncology and Biostatistics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 21:483-9. 2003..Salvage neoadjuvant androgen deprivation therapy may improve short-term biochemical control, but it requires further study...
High-dose-rate intraoperative brachytherapy for recurrent colorectal cancerK M Alektiar
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Int J Radiat Oncol Biol Phys 48:219-26. 2000..This is an update of our preliminary report with longer follow-up and larger patient numbers...
Pretreatment nomogram for predicting the outcome of three-dimensional conformal radiotherapy in prostate cancerM W Kattan
Departments of Urology, Epidemiology and Biostatistics, and Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
J Clin Oncol 18:3352-9. 2000..The purpose of this study was to develop a nomogram to improve the accuracy of predicting outcome after three-dimensional conformal radiotherapy...
The 1999 patterns of care study of radiotherapy in localized prostate carcinoma: a comprehensive survey of prostate brachytherapy in the United StatesW Robert Lee
Department of Radiation Oncology, Wake Forest University School of Medicine, Winston Salem, North Carolina 27157, USA
Cancer 98:1987-94. 2003..The objective of the current study was to provide descriptive information on a representative national sample of patients with prostate carcinoma who were treated with prostate brachytherapy (PB) in calendar year 1999...
A survival model for fractionated radiotherapy with an application to prostate cancerM Zaider
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Phys Med Biol 46:2745-58. 2001....
Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting--the MSKCC experienceBradford S Hoppe
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 67:691-702. 2007..To perform a retrospective analysis of patients with paranasal sinus (PNS) cancer treated with postoperative radiotherapy (RT) at Memorial Sloan-Kettering Cancer Center...
Customized dose prescription for permanent prostate brachytherapy: insights from a multicenter analysis of dosimetry outcomesNelson N Stone
Mount Sinai School of Medicine, New York, NY, USA
Int J Radiat Oncol Biol Phys 69:1472-7. 2007..To investigate the biochemical control rate in patients undergoing permanent prostate brachytherapy as a function of the biologically effective dose (BED) and risk group...
Long-term neck control rates after complete response to chemoradiation in patients with advanced head and neck cancerRamesh Rengan
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Am J Clin Oncol 31:465-9. 2008..To examine the long-term neck failure outcome in patients with advanced head and neck cancer treated on larynx/organ preservation protocols at Memorial Sloan-Kettering Cancer Center...
Postoperative intensity-modulated radiation therapy for cancers of the paranasal sinuses, nasal cavity, and lacrimal glands: technique, early outcomes, and toxicityBradford S Hoppe
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, New York 10021, USA
Head Neck 30:925-32. 2008....
Treatment planning and delivery of intensity-modulated radiation therapy for primary nasopharynx cancerM A Hunt
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, Box 84, 1275 York Avenue, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 49:623-32. 2001..To implement intensity-modulated radiation therapy (IMRT) for primary nasopharynx cancer and to compare this technique with conventional treatment methods...
Morbidity of adjuvant brachytherapy in soft tissue sarcoma of the extremity and superficial trunkK M Alektiar
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 47:1273-9. 2000..The purpose of this study was to evaluate the toxicity associated with adjuvant BRT in terms of wound complications, bone fracture, and peripheral nerve damage...
Risk group dependence of dose-response for biopsy outcome after three-dimensional conformal radiation therapy of prostate cancerSabine Levegrun
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Radiother Oncol 63:11-26. 2002..We fit phenomenological tumor control probability (TCP) models to biopsy outcome after three-dimensional conformal radiation therapy (3D-CRT) of prostate cancer patients to quantify the local dose-response of prostate cancer...
Clinical nodal stage is an independently significant predictor of distant failure in patients with squamous cell carcinoma of the larynxJeannette Marie S Matsuo
Head and Neck Service, Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York, USA
Ann Surg 238:412-21; discussion 421-2. 2003..CONCLUSION: Regardless of the index treatment modality, primary tumor site, or T stage, a higher clinical N stage at the time of presentation independently and significantly increases the risk of DM in patients with SCCL...
Intensity-modulated radiotherapy for head and neck cancer of unknown primary: toxicity and preliminary efficacyMichelle L Klem
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10022, USA
Int J Radiat Oncol Biol Phys 70:1100-7. 2008..With conventional techniques, significant toxicity can develop. Intensity-modulated radiotherapy (IMRT) has the potential to minimize the toxicity...
Predicting post-external beam radiation therapy PSA relapse of prostate cancer using pretreatment MRIMichael H Fuchsjäger
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10065, USA
Int J Radiat Oncol Biol Phys 78:743-50. 2010..To investigate whether pretreatment endorectal magnetic resonance imaging (MRI) findings can predict biochemical relapse in patients with clinically localized prostate cancer treated with external beam radiation therapy (EBRT)...
Long-term multi-institutional analysis of stage T1-T2 prostate cancer treated with radiotherapy in the PSA eraDeborah A Kuban
Department of Radiation Oncology, The University of Texas M D Anderson Cancer Center, Houston 77030, USA
Int J Radiat Oncol Biol Phys 57:915-28. 2003..To report the long-term outcome for patients with Stage T1-T2 adenocarcinoma of the prostate definitively irradiated in the prostate-specific antigen (PSA) era...
A method of incorporating organ motion uncertainties into three-dimensional conformal treatment plansG S Mageras
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 35:333-42. 1996..We describe a method of incorporating organ motion into three-dimensional (3D) conformal treatment plans, which predicts the effect of organ motion on the calculated dose to both the clinical target volume (CTV) and nontarget organs...
Intraoperative dynamic dosimetry for prostate implantsD A Todor
Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Phys Med Biol 48:1153-71. 2003..To offset the effect of organ motion the comparison was performed in terms of the proximity function of the two seed distributions. The agreement between the intra- and post-operative seed distributions was excellent...
Physician visits prior to treatment for clinically localized prostate cancerThomas L Jang
Department of Surgery, Sidney Kimmel Center for Prostate and Urologic Cancers, New York, New York, USA
Arch Intern Med 170:440-50. 2010..We evaluated how visits to specialists and primary care physicians (PCPs) by men with localized prostate cancer are related to treatment choice...
High-dose-rate intraoperative radiation therapy for recurrent head-and-neck cancerDavid J Perry
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 76:1140-6. 2010..To report the use of high-dose-rate intraoperative radiation therapy (HDR-IORT) for recurrent head-and-neck cancer (HNC) at a single institution...
Ultra-high dose (86.4 Gy) IMRT for localized prostate cancer: toxicity and biochemical outcomesOren Cahlon
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY, USA
Int J Radiat Oncol Biol Phys 71:330-7. 2008..To report toxicity and preliminary biochemical outcomes with high-dose intensity-modulated radiation therapy (IMRT) to a dose of 86.4 Gy for localized prostate cancer...
Predictive factors for late genitourinary and gastrointestinal toxicity in patients with prostate cancer treated with adjuvant or salvage radiotherapyMary Feng
Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109 0010, USA
Int J Radiat Oncol Biol Phys 68:1417-23. 2007..To determine the rate and magnitude of late genitourinary (GU) and gastrointestinal (GI) toxicities after salvage or adjuvant radiotherapy (RT) for prostate cancer, and to determine predictive factors for these toxicities...
Improved biochemical disease-free survival of men younger than 60 years with prostate cancer treated with high dose conformal external beam radiotherapyMichael J Zelefsky
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, 1275 York Avenue, New York, NY 10021, USA
J Urol 170:1828-32. 2003....
Normalization of serum testosterone levels in patients treated with neoadjuvant hormonal therapy and three-dimensional conformal radiotherapy for prostate cancerGilbert D A Padula
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 52:439-43. 2002..Lower baseline testosterone levels predict for a delay in testosterone normalization, and the persistence of symptoms related to androgen deprivation correlates with low testosterone levels...
Time trends in organ position and volume in patients receiving prostate three-dimensional conformal radiotherapyJames G Mechalakos
Department of Medical Physics, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Radiother Oncol 62:261-5. 2002..The subset of patients undergoing hormone therapy was also tested and did not independently exhibit any significant time trends...
Salvage radiotherapy for recurrent prostate cancer after radical prostatectomyAndrew J Stephenson
Department of Urology, Sidney Kimmel Center for Prostate and Urologic Cancers, Memorial Sloan-Kettering Cancer Center, New York, NY, USA
JAMA 291:1325-32. 2004..Selected patients with high-grade disease and/or a rapid PSADT who were previously thought to be destined to develop progressive metastatic disease may achieve a durable response to salvage radiotherapy...
Histopathologic effects of three-dimensional conformal external beam radiation therapy on benign and malignant prostate tissuesP B Gaudin
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Am J Surg Pathol 23:1021-31. 1999..The effects of 3DCRT on prostate cancer are variable, with some cases showing profound therapy-related changes and others showing no apparent therapy effect...
Failure of a 3D conformal boost to improve radiotherapy for nasopharyngeal carcinomaS L Wolden
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 49:1229-34. 2001..To determine whether the use of 3-dimensional (3D) boost for patients with nasopharynx cancer improves local control and reduces the risk of long-term complications...
Intraoperative high-dose-rate brachytherapy for pediatric solid tumors: a 10-year experienceKaryn A Goodman
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Brachytherapy 2:139-46. 2003..IOHDR alone may not be appropriate in the majority of patients. Subacute toxicities occurred rarely and may be related to the combination of extensive surgery, EBRT, and multi-agent chemotherapy in this population...
Unresectable carcinoma of the paranasal sinuses: outcomes and toxicitiesBradford S Hoppe
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York, USA
Int J Radiat Oncol Biol Phys 72:763-9. 2008..To evaluate long-term outcomes and toxicity in patients with unresectable paranasal sinus carcinoma treated with radiotherapy, with or without chemotherapy...
Multicenter analysis of effect of high biologic effective dose on biochemical failure and survival outcomes in patients with Gleason score 7-10 prostate cancer treated with permanent prostate brachytherapyNelson N Stone
Mount Sinai School of Medicine, New York, NY, USA
Int J Radiat Oncol Biol Phys 73:341-6. 2009..To investigate the biochemical control rates and survival for Gleason score 7-10 prostate cancer patients undergoing permanent prostate brachytherapy as a function of the biologic effective dose (BED)...
Tolerance of tissue transfers to adjuvant radiation therapy in primary soft tissue sarcoma of the extremityMarnee M Spierer
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 56:1112-6. 2003..the direct result of BRT needs further investigation...
Intensity-modulated radiotherapySteven A Leibel
Department of Radiation Oncology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
Cancer J 8:164-76. 2002..The implementation of biologic evaluation of tumor sensitivity, in addition to methods that improve target delineation and dose delivery, represents a new dimension in intensity-modulated radiotherapy research...
PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysisMichael E Ray
Department of Radiation Oncology, University of Michigan, Ann Arbor, MI 48109 0010, USA
Int J Radiat Oncol Biol Phys 64:1140-50. 2006....
Endorectal MR imaging before salvage prostatectomy: tumor localization and stagingEvis Sala
Department of Radiology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, New York, NY 10021, USA
Radiology 238:176-83. 2006....
Fluoroscopically guided interventional procedures: a review of radiation effects on patients' skin and hairStephen Balter
Department of Medicine, Columbia University Medical Center, 627 W 165th St, New York, NY 10021, USA
Radiology 254:326-41. 2010..If the same area of skin is likely to be exposed to levels higher than a few grays, the effects of previous irradiation should be included when estimating the expected tissue reaction from the additional procedure...
Nadir prostate-specific antigen within 12 months after radiotherapy predicts biochemical and distant failureMichael E Ray
Department of Radiation Oncology, University of Michigan Medical Center, Ann Arbor, Michigan 48109 0010, USA
Urology 68:1257-62. 2006..To determine whether nadir prostate-specific antigen (PSA) levels within 12 months (nadir PSA12) after completion of radiotherapy (RT) can be used as an early marker of recurrence risk...
Results of high dose rate brachytherapy, anterior pelvic exenteration and external beam radiotherapy for carcinoma of the female urethraG Dalbagni
Department of Urology, Memorial Sloan-Kettering Cancer Center, New York, New York 10021, USA
J Urol 166:1759-61. 2001..Local control seems to have improved. We must evaluate a larger cohort of patients to determine this impact of the combined modality on local control and patient survival...
The indications for elective treatment of the neck in cancer of the major salivary glandsJ G Armstrong
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021
Cancer 69:615-9. 1992..High-grade tumors and larger tumors have a high rate of occult neck metastases, and treatment should be considered in this group...
Development of a semi-automatic alignment tool for accelerated localization of the prostateChiaho Hua
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 55:811-24. 2003..A rapid computed tomography (CT)-based online prostate localization method is presented for this purpose...
Variation in adherence to external beam radiotherapy quality measures among elderly men with localized prostate cancerJustin E Bekelman
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 69:1456-66. 2007..S. men...
The significance of the amount of myometrial invasion in patients with Stage IB endometrial carcinomaKaled M Alektiar
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Cancer 95:316-21. 2002..The objective of this study was to determine whether the depth of myometrial invasion is correlated with outcome in patients with Stage IB endometrial carcinoma...
The Anderson nomograms for permanent interstitial prostate implants: a briefing for practitionersGil ad N Cohen
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 53:504-11. 2002..e., patient-to-patient and planner-to-planner variability). In each case, the computer-optimization system for intraoperative planning currently in use at our institution was taken as the "gold standard."..
Adjuvant brachytherapy for primary high-grade soft tissue sarcoma of the extremityKaled M Alektiar
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
Ann Surg Oncol 9:48-56. 2002..We reviewed single-institution experience using brachytherapy alone for primary high-grade soft tissue sarcoma of the extremity...
Clinically significant prostate cancer local recurrence after radiation therapy occurs at the site of primary tumor: magnetic resonance imaging and step-section pathology evidenceDarko Pucar
Department of Radiology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 69:62-9. 2007....
Biochemical and clinical significance of the posttreatment prostate-specific antigen bounce for prostate cancer patients treated with external beam radiation therapy alone: a multiinstitutional pooled analysisEric M Horwitz
Department of Radiation Oncology, Fox Chase Cancer Center, Philadelphia, Pennsylvania, USA
Cancer 107:1496-502. 2006....
Role of external beam radiotherapy in patients with advanced or recurrent nonanaplastic thyroid cancer: Memorial Sloan-kettering Cancer Center experienceStephanie A Terezakis
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 73:795-801. 2009..External beam radiotherapy (EBRT) plays a controversial role in the management of nonanaplastic thyroid cancer. We reviewed our institution's outcomes in patients treated with EBRT for advanced or recurrent nonanaplastic thyroid cancer...
Dosimetric and anatomic indicators of late rectal toxicity after high-dose intensity modulated radiation therapy for prostate cancerReshma Munbodh
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, New York 10065, USA
Med Phys 35:2137-50. 2008..Late rectal toxicity was related to the irradiation of the upper part of the rectum and also to the absolute area irradiated, PTV size, and rectum size on the planning computed tomography (CT) scan...
Favorable clinical outcomes of three-dimensional computer-optimized high-dose-rate prostate brachytherapy in the management of localized prostate cancerYoshiya Yamada
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Brachytherapy 5:157-64. 2006..To report PSA relapse-free survival and toxicity outcomes of prostate cancer patients who have undergone three-dimensional computer-optimized high-dose-rate (HDR) brachytherapy with external beam radiotherapy as definitive treatment...
Adjuvant radiotherapy for margin-positive high-grade soft tissue sarcoma of the extremityK M Alektiar
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 48:1051-8. 2000..The purpose of this study was to determine if adjuvant RT improves local control in patients with high-grade STS who had positive margins of resection...
Pretreatment nomogram that predicts 5-year probability of metastasis following three-dimensional conformal radiation therapy for localized prostate cancerMichael W Kattan
Department of Urology, Memorial Sloan Kettering Cancer Center, 1275 York Ave, Box 27, New York, NY 10021, USA
J Clin Oncol 21:4568-71. 2003..The goal of this study was to create and to externally validate a nomogram for predicting the probability that a patient will develop metastasis within 5 years after three-dimensional conformal radiation therapy (CRT)...
Single-fraction intraoperative radiotherapy for breast cancer: early cosmetic resultsKathryn Beal
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 69:19-24. 2007..To evaluate the cosmetic outcome of patients treated with wide local excision and intraoperative radiotherapy for early-stage breast cancer...
Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomyAndrew J Stephenson
Glickman Urological Institute, Cleveland Clinic Foundation, Cleveland, OH 44195 0001, USA
J Clin Oncol 25:2035-41. 2007..We developed a nomogram to predict the probability of cancer control at 6 years after SRT for PSA-defined recurrence...
Critical organ dosimetry in permanent seed prostate brachytherapy: defining the organs at riskJuanita M Crook
Department of Radiation Oncology, Princess Margaret Hospital, Toronto, Canada
Brachytherapy 4:186-94. 2005..We set out to examine the existing data and propose a uniform method of reporting such that results from different centers can more easily be compared...
Assessment of radiation safety instructions to patients based on measured dose rates following prostate brachytherapyLawrence T Dauer
Department of Medical Physics, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Brachytherapy 3:1-6. 2004..To validate radiation safety instructions to patients and to evaluate the potential radiation doses to members of the public after (125)I or (103)Pd prostate implantation...
A comparison of intensity-modulated radiation therapy and concomitant boost radiotherapy in the setting of concurrent chemotherapy for locally advanced oropharyngeal carcinomaNancy Y Lee
Department of Radiation Oncology, Memorial Sloan Kettering Cancer Center, New York, NY 10021, USA
Int J Radiat Oncol Biol Phys 66:966-74. 2006..intensity-modulated radiotherapy (IMRT) in the setting of concurrent chemotherapy (CT) for locally advanced oropharyngeal carcinoma...
